What is the impact of capsule endoscopy in the long term period?

doi:10.4253/wjge.v8.i7.344

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8539)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

464

WORD

280

HTML

2785

Tables (1-4)

285

Sum=3814

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

561

Download

1313

Sum=1874

Publishing Process of This Article

Item

Count

Browse

1014

Download

1837

Sum=2851

Apr 10, 2016 (publication date) through Feb 18, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Endosc. Apr 10, 2016; 8(7): 344-348
Published online Apr 10, 2016. doi: 10.4253/wjge.v8.i7.344

Table 2 Evalution of rebleeding according to the demographic data n (%)

		Rebleeding		P
		(+)	(-)
Age, n (%)	< 70 yr	32 (32)	68 (68)	¹0.001^b
	> 70 yr	24 (61.5)	15 (38.5)
Comorbidity		33 (66)	17 (34)	²0.001^b
OGIB
Overt		42 (48.8)	44 (51.2)	²0.015^a
Occult		14 (26.4)	39 (73.6)
Vasculary lesion		31 (72.1)	12 (27.9)	²0.001^b
Positive capsule result		55 (46.6)	63 (53.4)	²0.001^b
NSAIDs-anticoagulant antiaggregant therapy		19 (73.1)	7 (26.9)	²0.001^b

¹Pearson Ki-kare test;

²Yates’ Continuity Correction test.

^aP < 0.05;

^bP < 0.01. OGIB: Obscure gastrointestinal bleeding; NSAIDs: Non-steroidal anti-inflammatory drugs.

Citation: Ormeci A, Akyuz F, Baran B, Gokturk S, Ormeci T, Pinarbasi B, Soyer OM, Evirgen S, Akyuz U, Karaca C, Demir K, Kaymakoglu S, Besisik F. What is the impact of capsule endoscopy in the long term period? World J Gastrointest Endosc 2016; 8(7): 344-348
URL: https://www.wjgnet.com/1948-5190/full/v8/i7/344.htm
DOI: https://dx.doi.org/10.4253/wjge.v8.i7.344